Sign in

Eric Bjornholt

Senior Vice President and Chief Financial Officer at MICROCHIP TECHNOLOGYMICROCHIP TECHNOLOGY
Executive

About Eric Bjornholt

J. Eric Bjornholt is Senior Vice President and Chief Financial Officer of Microchip Technology, serving as CFO since January 2009 after joining the company in 1995; he is 54 years old and holds a Master’s in Taxation (Arizona State University) and a B.S. in Accounting (University of Arizona) . Company performance context: Microchip reported FY2025 net sales of $4.40 billion , non-GAAP operating income of $1,078.0 million (24.5% margin) , and a TSR index value of 155.82 for FY2025 in the SEC’s pay-versus-performance disclosure .

Past Roles

OrganizationRoleYearsStrategic Impact
Microchip TechnologyChief Financial OfficerJan 2009–present Long-tenured finance leadership through cycles and incentive program alignment
Microchip TechnologyVice President, Finance2008–Jan 2009 Progression to CFO; built finance capabilities
Microchip TechnologyVarious financial management roles1995–2008 Continuity in finance operations and controls
Microchip TechnologySenior Vice President2019–present Elevated executive responsibilities

External Roles

  • None disclosed in company filings .

Fixed Compensation

MetricFY2023FY2024FY2025
Base Salary ($)315,212 324,351 264,195
MICP Target Bonus (% of Salary)44% 44%
MICP Actual Payout ($)378,797 117,118 0 (no payout all quarters)
ECBP Bonus ($)36,894 10,161 0
Salary Reduction Program Note20% reduction began Feb 2024 20% reduction continued until Mar 31, 2025

Performance Compensation

Microchip’s Management Incentive Compensation Plan (MICP) uses quarterly targets with defined weightings; no FY2025 payouts were made to executives due to performance shortfalls.

Metric / WeightingQ1 FY2025 Target & WeightQ2 FY2025 Target & WeightQ3 FY2025 Target & WeightQ4 FY2025 Target & Weight
Sequential net sales growth1.50% (20%) 3.50% (20%) 3.50% (20%) 3.50% (20%)
Non-GAAP gross profit %65.50% (15%) 63.50% (15%) 63.50% (15%) 63.50% (15%)
Non-GAAP opex % of net sales23.00% (15%) 25.50% (15%) 25.50% (15%) 25.50% (15%)
Non-GAAP op. income % of net sales42.50% (15%) 38.00% (15%) 38.00% (15%) 38.00% (15%)
Non-GAAP diluted EPS$0.52 (15%) $0.43 (15%) $0.30 (15%) $0.10 (15%)
Discretionary (non-ESG)N/A (15%) N/A (15%) N/A (15%) N/A (20%)
Discretionary (ESG)N/A (5%) N/A (5%) N/A (5%) N/A (0%)
MICP Total100% 100% 100% 100%
Actual Results / PayoutQ1 FY2025 Actual & PayoutQ2 FY2025 Actual & PayoutQ3 FY2025 Actual & PayoutQ4 FY2025 Actual & Payout
Sequential net sales growth-6.37% (0%) -6.24% (0%) -11.84% (0%) -5.41% (0%)
Non-GAAP gross profit %59.90% (0%) 59.54% (0%) 55.44% (0%) 51.99% (0%)
Non-GAAP opex % of net sales28.43% (0%) 30.25% (0%) 34.91% (0%) 37.97% (0%)
Non-GAAP op. income % of net sales31.46% (0%) 29.29% (0%) 20.53% (0%) 14.02% (0%)
Non-GAAP diluted EPS$0.53 (0%) $0.46 (0%) $0.20 (0%) $0.11 (0%)
Discretionary (non-ESG)0% 0% 0% 0%
Discretionary (ESG)0% 0% 0% 0%
MICP Total0% 0% 0% 0%

Equity awards: since October 2021, 50% of evergreen RSUs are PSUs tied to 12-quarter non-GAAP operating income as a % of net sales; remaining 50% are time-based RSUs (~4-year vest) . No option grants since September 2015 .

Equity Ownership & Alignment

ItemDetail
Beneficial ownership39,659 shares; includes 5,346 RSUs vesting within 60 days of June 20, 2025; flagged as less than 1% of outstanding shares (539,674,554)
Stock ownership guidelinesSection 16(b) executive officers: minimum 2× annual salary or 12,000 shares; all executives and directors were in compliance in FY2025
Anti-hedging/pledgingCompany insider trading policy prohibits hedging, short sales, options trading, and pledging or margin holdings of Microchip securities
OptionsNo stock options outstanding or granted (companywide) as of FY2025

Selected outstanding awards and scheduled vesting (market value at $48.41/share):

Vest DateSharesMarket Value ($)
Feb 15, 20261,349 65,305
Feb 16, 2026678; 93 32,822; 4,502
May 15, 20261,690; 183 81,813; 8,859
Aug 15, 2026252 12,199
Aug 17, 20262,226 107,761
Nov 15, 2026296 14,329
Nov 16, 20262,945 142,567
Feb 15, 20272,713 131,336
May 17, 20272,380 115,216
Aug 15, 20272,226 107,761
Nov 15, 20272,512 121,606
Feb 15, 20282,274 110,084
May 15, 20282,194 106,212
Aug 15, 20282,149 104,033
Nov 15, 20282,540 122,961
Feb 15, 20293,461 167,547

Note: PSU achievement levels vary by grant cohort; FY2025 disclosures indicate some cohorts at 100–200% of target based on performance status as of March 31, 2025 (see footnotes for vesting contingencies and performance periods) .

Employment Terms

ProvisionTerms (CFO)
Employment contractNo employment contract; no severance outside change-of-control agreements
Change-of-control period3 months prior to CoC through 2 years post-CoC
Trigger typeDouble trigger: termination without cause (or resignation for good reason) during CoC period
Cash severance18 months base salary (then-current)
Bonus severance150% of highest annual incentive compensation paid in any of preceding 3 full plan years
BenefitsLump sum for 18 months COBRA premiums (medical, vision, dental) for executive + dependents
Equity vesting100% acceleration for service-based awards; performance-based awards vest at greater of target or per award terms
280G excise taxNo gross-up; cutback to avoid excise tax if economically optimal; waterfall ordering defined
ClawbackCompensation recovery (Nasdaq-compliant) adopted October 2023 for incentive-based compensation upon restatement
Minimum vestingEquity plan requires ≥1-year vesting for ≥95% of awards (limited exceptions)
Deferred compAggregate balance $708,302; aggregate earnings FY2025 $28,545; no company contributions
Perquisites401(k) match $3,963; life insurance premiums $2,174 (FY2025)

Performance & Track Record

  • Pay-versus-performance: FY2025 CAP (compensation actually paid) to non-PEO NEOs averaged -$1.46 million reflecting negative fair value changes in unvested equity amid downturn; Microchip TSR index 155.82 vs peer index 301.01 in FY2025 disclosure .
  • FY2025 operating context: Non-GAAP operating income $1,078.0 million; GAAP operating income $296.3 million; non-GAAP net income $708.8 million . No MICP payouts in FY2025, consistent with weak results .
  • Governance feedback: 94.22% Say-on-Pay support at August 20, 2024 meeting .

Compensation Structure Analysis

  • Equity-heavy incentives: Quarterly evergreen awards split roughly 50% PSUs (operating margin-based) and 50% time-based RSUs, increasing at-risk pay tied to profitability targets .
  • Cash incentives shut off: FY2025 MICP paid 0% in all quarters, demonstrating strict pay-for-performance alignment during downturn .
  • Risk controls tightened: Adoption of clawback (Oct 2023), minimum vesting, and removal of excise-tax gross-up in new CoC agreements (June 2024) .

Equity Ownership & Alignment (Expanded)

IndicatorAssessment
Skin in the game39,659 shares beneficially owned; RSUs vesting in 60 days included; below 1% of outstanding shares
Ownership guideline complianceExecutives were compliant in FY2025; CFO guideline is 2× salary or 12,000 shares
Hedging/pledging riskProhibited by policy (anti-hedging and anti-pledging)
Option riskNo options outstanding/granted; reduces leverage/volatility
Upcoming vesting cadenceMultiple RSU/PSU tranches vest across 2026–2029; may create periodic tax-driven selling windows

Investment Implications

  • Alignment: The zero cash bonus outcome in FY2025 and PSU linkage to non-GAAP operating margin indicate strong pay-for-performance discipline; equity-heavy mix supports retention and long-term focus .
  • Retention/pressure: A layered vesting schedule through 2029 suggests ongoing retention hooks; however, periodic vesting may lead to incremental selling pressure around vest dates for tax/liquidity, mitigated by anti-hedging/pledging policies .
  • Governance quality: Clawback, minimum vesting, and excise-tax cutback provisions are shareholder-friendly; strong say-on-pay support (94.22%) reduces governance risk .
  • Performance sensitivity: FY2025 MICP structure weighted to margins and EPS was stringent in downturn; forward PSU payouts depend on sustained recovery in operating margin per disclosed matrices, making equity realization sensitive to execution on cost, mix, and demand normalization .